APA (7th ed.) Citation

Wang, Q., Yang, S., Wang, K., & Sun, S. (2019). MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer. Journal of hematology and oncology, 12(1), 63-11. https://doi.org/10.1186/s13045-019-0759-9

Chicago Style (17th ed.) Citation

Wang, Qiming, Sen Yang, Kai Wang, and Shi-Yong Sun. "MET Inhibitors for Targeted Therapy of EGFR TKI-resistant Lung Cancer." Journal of Hematology and Oncology 12, no. 1 (2019): 63-11. https://doi.org/10.1186/s13045-019-0759-9.

MLA (9th ed.) Citation

Wang, Qiming, et al. "MET Inhibitors for Targeted Therapy of EGFR TKI-resistant Lung Cancer." Journal of Hematology and Oncology, vol. 12, no. 1, 2019, pp. 63-11, https://doi.org/10.1186/s13045-019-0759-9.